TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31609489

Group type: EXPERIMENTAL
Intervention: Waist-shaped inter-dental brushes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cylindric inter-dental brushes
Number of subjects: 20
Study: 31778439

Group type: COMPARATOR
Intervention: Functional electrical stimulation of lower limb muscles (FES group)
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Tai Chi exercise (TCE group)
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Functional electrical stimulation of lower limb muscles and Tai Chi exercise (FES & TCE group)
Number of subjects: 1084
Study: 28100342

Group type: EXPERIMENTAL
Intervention: Intracoronary administration of 6 mg nicorandil after guide wire or balloon successfully crossed the target lesion (n=53)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Intracoronary administration of 300 μg nitroglycerin after guide wire or balloon successfully crossed the target lesion (n=52)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Routine treatment (control group, n=53)
Number of subjects: 158
Study: 25880933

Group type: EXPERIMENTAL
Intervention: SMT19969 (up to 2,000 mg single oral doses)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: SMT19969 (200 mg BID for 10 days)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: SMT19969 (single and multiple oral doses)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: SMT19969 (multiple doses)
Number of subjects: 56
Study: 24020707

Group type: EXPERIMENTAL
Intervention: dexmedetomidine-propofol
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: dexmedetomidine-thiopenthal
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: dexmedetomidine-etomidate
Number of subjects: 76
Study: 21214361

Group type: EXPERIMENTAL
Intervention: Bimatoprost (BIM) 0.03%
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Bimatoprost/timolol fixed combination (BTFC) 0.03%/0.5%
Number of subjects: 33
Study: 19726292

Group type: EXPERIMENTAL
Intervention: Test preparation of ziprasidone (40 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference preparation of ziprasidone (40 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both test and reference preparations of ziprasidone
Number of subjects: 20
Study: 17846399

Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride, 150 mg twice a day
Number of subjects: 593

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593
Study: 15500895

Group type: EXPERIMENTAL
Intervention: Regularly scheduled albuterol treatment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: COMPARATOR
Intervention: Comparison of albuterol vs placebo
Number of subjects: 78
Study: 11686808

Group type: EXPERIMENTAL
Intervention: Surgical therapy (SU)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-surgical scaling and root planing (SRP)
Number of subjects: 64
Study: 9573448

Group type: EXPERIMENTAL
Intervention: Test lunch 1 (1200 kcal, 38% carbohydrate, 50% fat, 12% protein)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Test lunch 2 (1200 kcal, 38% carbohydrate, 50% fat, 12% protein)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both meals
Number of subjects: 12
Study: 7934734

Group type: EXPERIMENTAL
Intervention: Antinicotinic therapeutic films containing anabasinum, cytisinum, or their combination in equal ratios applied to the gingiva beneath the upper lip.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Antinicotinic therapeutic films containing cytisinum and anabasinum in combination or cytisinum alone.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Antinicotinic therapeutic films.
Number of subjects: 74
Study: 3602023

Group type: EXPERIMENTAL
Intervention: Commercially-available bowel evacuant kit (magnesium citrate oral solution, phenolphthalein tablets, bisacodyl suppository)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Castor oil with enemas
Number of subjects: 195
Study: 29607595

Group type: EXPERIMENTAL
Intervention: Telephone follow-up nursing intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 43
Study: 28825891

Group type: EXPERIMENTAL
Intervention: Probucol (cholesterol-lowering agent) treatment for 6 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 24
Study: 25545594

Group type: EXPERIMENTAL
Intervention: Late post-pandemic period
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Patients who died
Number of subjects: 172
Study: 23907204

Group type: EXPERIMENTAL
Intervention: WBRT + TMZ 75 mg/m² for 2 weeks followed by TMZ 100 mg/m²/day 2 weeks on/2 weeks off for up to 6 months (RCT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: WBRT alone (RT)
Number of subjects: 35
Study: 21079746

Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe) and betaine with pegIFNα2b and ribavirin
Number of subjects: 29

Group type: COMPARATOR
Intervention: pegIFNα/ribavirin
Number of subjects: 29
Study: 17892457

Group type: EXPERIMENTAL
Intervention: Loupes-assisted nerve-sparing radical hysterectomy (NSRH)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional radical hysterectomy type II (RH type II)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional radical hysterectomy type III (RH type III)
Number of subjects: 18
Study: 15725986

Group type: EXPERIMENTAL
Intervention: Universal group (BMD testing offered to all); 1986 contacted, 415 participated
Number of subjects: 4167

Group type: EXPERIMENTAL
Intervention: SCORE group (BMD testing for women scoring >= 7 on SCORE questionnaire); 1940 contacted, 576 participated
Number of subjects: 4167

Group type: COMPARATOR
Intervention: SOF-based group (BMD testing for women with >= 5 hip fracture risk factors); 5342 contacted, 2176 participated
Number of subjects: 4167

Group type: EXPERIMENTAL
Intervention: Universal group
Number of subjects: 4167

Group type: COMPARATOR
Intervention: SOF-based group
Number of subjects: 4167
Study: 12555300

Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 205

Group type: COMPARATOR
Intervention: Diathermy haemorrhoidectomy
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 205
Study: 10376694

Group type: EXPERIMENTAL
Intervention: Single treatment (9 subjects)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Multiple treatments (58 subjects)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 67
Study: 8905942

Group type: EXPERIMENTAL
Intervention: Lidocaine tape (Penles) applied 30-60 min before epidural block (groups 1 and 2)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Eutectic mixture of lidocaine and tetracaine (LT ointment) applied 1-2 h before block (group 3)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Midazolam 5 mg intramuscularly (groups 2 and 3)
Number of subjects: 96
Study: 1867967

Group type: EXPERIMENTAL
Intervention: Oxazepam 15 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7144761

Group type: EXPERIMENTAL
Intervention: Vitamin E (20 mg/kg i.m. daily during artificial ventilation for up to 14 days)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no vitamin E treatment)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Vitamin E group
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 30938809

Group type: EXPERIMENTAL
Intervention: Lohmann Dual (LD) hens
Number of subjects: 2071

Group type: EXPERIMENTAL
Intervention: Lohmann Dual (LD) eggs
Number of subjects: 2071

Group type: EXPERIMENTAL
Intervention: Experimental crosses (DR, DS, KK hens mated with genetically different males)
Number of subjects: 2071

Group type: EXPERIMENTAL
Intervention: Artificial insemination (AI) for NC and LD
Number of subjects: 2071

Group type: EXPERIMENTAL
Intervention: Parental meat-type males of NC and LD
Number of subjects: 2071

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 2071
Study: 28755266

Group type: EXPERIMENTAL
Intervention: Latiglutenase (900 mg, n=14)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Latiglutenase
Number of subjects: 398

Group type: COMPARATOR
Intervention: Placebo (n=54)
Number of subjects: 398
Study: 25823136

Group type: EXPERIMENTAL
Intervention: Chiropractic treatment in addition to dexamethasone and methycobal; chiropractic included local muscle loosening, attacking point, bilateral pulling atlanto-axial joint, continuous treatment for 10 days.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dexamethasone intravenous drip of 10 mg for 3 days, decreased to 5 mg for another 3 days; methycobal intravenous drip of 500 μg for 10 days.
Number of subjects: 90
Study: 23317632

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 491

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Adjudicated bleeding assessments
Number of subjects: 491
Study: 21671125

Group type: EXPERIMENTAL
Intervention: Gaze training (GAZE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Movement training (MOVE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Discovery learning/control (DISCOVERY)
Number of subjects: 30
Study: 18929492

Group type: EXPERIMENTAL
Intervention: Single tube (32F chest tube)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Double tube (2 x 32F chest tubes)
Number of subjects: 100
Study: 18085028

Group type: EXPERIMENTAL
Intervention: Prilocaine plus meperidine (Group MP): 5 ml fluid combination containing prilocaine (10 mg/ml) and meperidine (1 mg/kg) injected into nasal packs 15 minutes before removal
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prilocaine (Group P): 5 ml of 1% prilocaine in saline injected into the pack 15 minutes before removal
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control: 5 ml saline injected into the contra-lateral nostril in both groups
Number of subjects: 50
Study: 16279253

Group type: EXPERIMENTAL
Intervention: Different therapeutic strategies in HIV disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data management processes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collaboration of three governmental agencies
Number of subjects: 0
Study: 11471515

Group type: EXPERIMENTAL
Intervention: Etanercept (Enbrel‐‐Wyeth)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infliximab (Remicade‐‐Schering Plough)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9792490

Group type: EXPERIMENTAL
Intervention: Flight phobics; aHR when entering the plane: 17.5 bpm
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-anxious controls; aHR when entering the plane: 9.9 bpm
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Flight phobics; aHR when leaving the hospital: 7.0 bpm
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-anxious controls; aHR when leaving the hospital: 8.6 bpm
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Flight phobics; Raw HR when leaving the hospital: 118 bpm
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-anxious controls; Raw HR when leaving the hospital: 114 bpm
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Flight phobics; Raw HR when entering the plane: 117 bpm
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-anxious controls; Raw HR when entering the plane: 110 bpm
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Flight phobics; V during any condition: not higher than controls
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-anxious controls; V during any condition: not higher than phobics
Number of subjects: 43
Study: 7997841

Group type: EXPERIMENTAL
Intervention: Non-smoking pregnant women
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Smoking pregnant women
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (healthy non-smoking females)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Comparison of non-smoking vs smoking pregnant women
Number of subjects: 215
Study: 3057398

Group type: EXPERIMENTAL
Intervention: Oral physostigmine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31775515

Group type: EXPERIMENTAL
Intervention: RCL intervention
Number of subjects: 267
Study: 30839301

Group type: EXPERIMENTAL
Intervention: 5 minute static stretching
Number of subjects: 17

Group type: COMPARATOR
Intervention: 5 minute control period
Number of subjects: 17
Study: 28038810

Group type: EXPERIMENTAL
Intervention: LVAD pump speed set at 4
Number of subjects: 15

Group type: COMPARATOR
Intervention: LVAD pump speed set at 2
Number of subjects: 15
Study: 26154494

Group type: EXPERIMENTAL
Intervention: tPCS at 6-10 Hz
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: tPCS at 11-15 Hz
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study: 23412704

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg single dose
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo 500 mg single dose
Number of subjects: 276
Study: 21620555

Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127)
Number of subjects: 213

Group type: COMPARATOR
Intervention: No intervention (Control group, n=86)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with bilateral hydatid
Number of subjects: 213

Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with bilateral hydatid
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with fimbrial hydatid
Number of subjects: 213

Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with fimbrial hydatid
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with single hydatid
Number of subjects: 213

Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with single hydatid
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with hydatid diameter of 1-2 cm
Number of subjects: 213

Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with hydatid diameter of 1-2 cm
Number of subjects: 213
Study: 18461849

Group type: EXPERIMENTAL
Intervention: Interdisciplinary treatment at the Basel clinic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal sample)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temperament ratings by mothers of treated children
Number of subjects: 0
Study: 17078217

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of bone marrow autologous mononuclear cells (BMAMC) after stenting the coronary artery, performed on AMI day 7-21.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no BMAMC treatment).
Number of subjects: 26
Study: 12616005

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dietary caffeine consumption
Number of subjects: 20
Study: 10878144

Group type: EXPERIMENTAL
Intervention: Gun safety counseling intervention (60-second message about gun safety)
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 1295
Study: 8883532

Group type: EXPERIMENTAL
Intervention: Iodixanol at 270 mg I/ml
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Iodixanol at 320 mg I/ml
Number of subjects: 150

Group type: COMPARATOR
Intervention: Iohexol at 300 mg I/ml
Number of subjects: 150
Study: 1555904

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 27
Study: 4003142

Group type: EXPERIMENTAL
Intervention: 1.32 mg/kg of 95% USP alcohol
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 31984648

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard diet (Control)
Number of subjects: 45
Study: 30553555

Group type: EXPERIMENTAL
Intervention: Low-dose (150 mg) pregabalin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-dose (300 mg) pregabalin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 90
Study: 28113680

Group type: EXPERIMENTAL
Intervention: Greedy deterministic approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bandit-based algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exact versions of OMP or FW algorithms
Number of subjects: 0
Study: 27619564

Group type: EXPERIMENTAL
Intervention: EQClinic training during weeks 1-5 (group A)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Teleconsultation between the two face-to-face consultations (group B)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: EQClinic training before the first face-to-face consultation (group A)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Course curriculum components only (group B)
Number of subjects: 268
Study: 24732447

Group type: EXPERIMENTAL
Intervention: Streptococcus pneumoniae meningitis
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Haemophilus influenzae meningitis
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Overall comparison of pneumococcal vs H.influenzae meningitis
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Patients who succumbed within 8 hours
Number of subjects: 206
Study: 22496401

Group type: EXPERIMENTAL
Intervention: Early-invitation group (started receiving food supplements at 9 weeks gestation)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual-invitation group (started receiving food supplements at 20 weeks gestation)
Number of subjects: 180
Study: 19413491

Group type: EXPERIMENTAL
Intervention: Older individuals (≥65 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Younger individuals (<65 years)
Number of subjects: 0
Study: 17380562

Group type: EXPERIMENTAL
Intervention: Transfusion Risk Score (TRS) based on clinicopathological factors including preoperative haemoglobin concentration below 12.5 g/dl, largest tumour more than 4 cm, need for exposure of the vena cava, need for an associated procedure, and cirrhosis.
Number of subjects: 480
Study: 15084207

Group type: EXPERIMENTAL
Intervention: General population (HRV measures)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: General population (LF, HF, total frequency power)
Number of subjects: 149

Group type: COMPARATOR
Intervention: AMI patients (HRV measures)
Number of subjects: 149

Group type: COMPARATOR
Intervention: AMI patients (LF power distribution)
Number of subjects: 149
Study: 12374430

Group type: EXPERIMENTAL
Intervention: Cellular replacement therapy using mesencephalic brain cells from fetal cadavers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New methods to increase transplant survival and distribution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neural transplantation
Number of subjects: 0
Study: 9520913

Group type: EXPERIMENTAL
Intervention: Theophylline (plasma concentrations between 15-20 micrograms/ml)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 24
Study: 7517442

Group type: EXPERIMENTAL
Intervention: MACOP-B
Number of subjects: 221

Group type: COMPARATOR
Intervention: ProMACE-MOPP
Number of subjects: 221
Study: 2702169

Group type: EXPERIMENTAL
Intervention: Fluoride iontophoresis (initial treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoride iontophoresis (second treatment after 4 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoride iontophoresis (third application)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 4753234

Group type: EXPERIMENTAL
Intervention: Diazepam administration (30 mg or less)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Diazepam administration (larger doses)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Measurement of plasma levels of diazepam and its active metabolite
Number of subjects: 1
Study: 31787152

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 235
Study: 30959415

Group type: EXPERIMENTAL
Intervention: Small financial incentives for smoking abstinence
Number of subjects: 75
Study: 28100525

Group type: EXPERIMENTAL
Intervention: Peres' formula (P)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Radiological landmark-based technique (R)
Number of subjects: 188
Study: 26083705

Group type: EXPERIMENTAL
Intervention: Skiing intervention (12-week duration)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no skiing intervention)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Skiing intervention
Number of subjects: 34
Study: 23773310

Group type: EXPERIMENTAL
Intervention: Morning bright-light therapy (10,000 lux)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inactive light (100 lux)
Number of subjects: 60
Study: 21612143

Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg/Kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/Kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ketamine 0.125 mg/Kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline)
Number of subjects: 120
Study: 19849639

Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system (MTS)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 16796730

Group type: EXPERIMENTAL
Intervention: WS 5570 600 mg/day
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: WS 5570 1200 mg/day
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: WS 5570 600 mg/day and WS 5570 1200 mg/day
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 332
Study: 19777696

Group type: EXPERIMENTAL
Intervention: High dose interferon-alpha (HD IFN)
Number of subjects: 0
Study: 11157827

Group type: EXPERIMENTAL
Intervention: HMG
Number of subjects: 40

Group type: COMPARATOR
Intervention: rhFSH
Number of subjects: 40
Study: 9404441

Group type: EXPERIMENTAL
Intervention: Pituitary stimulation tests (GnRH and TRH injections)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Higher free oestradiol index in test subjects
Number of subjects: 47
Study: 8124019

Group type: EXPERIMENTAL
Intervention: Cryoprobe at -70 degrees C
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Cryoprobe at -82 degrees C
Number of subjects: 128
Study: 3126455

Group type: EXPERIMENTAL
Intervention: Modified cellulose (Hemophan)
Number of subjects: 2